PMID- 23228281 OWN - NLM STAT- MEDLINE DCOM- 20140717 LR - 20151119 IS - 1873-4898 (Electronic) IS - 1477-5131 (Linking) VI - 9 IP - 6 Pt A DP - 2013 Dec TI - Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis. PG - 838-45 LID - S1477-5131(12)00285-9 [pii] LID - 10.1016/j.jpurol.2012.11.011 [doi] AB - OBJECTIVE: Hydronephrosis is diagnosed in 0.5% of all newborns, and ureteropelvic junction obstruction (UPJO) is a common cause. The aim of this study was to test whether specific urinary cytokines can be used as UPJO biomarkers in children with hydronephrosis. MATERIALS AND METHODS: Twenty-eight children referred for pyeloplasty due to UPJO and 13 controls were included in this prospective study. Kidney function was assessed and urine samples collected pre-, peri-, and post-operatively. Urine levels of epidermal growth factor (EGF), monocyte chemotactic peptide-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha), interferon-gamma-inducible protein-10 (IP-10), and RANTES were measured simultaneously by using a bead-based multiplex sandwich immunoassay. RESULTS: In hydronephrotic children, preoperative urine levels were significantly increased for EGF (median 7.4 [1.2-60.2] vs. median 4.0 [1.2-13.8] ng/mg creatinine) and MCP-1 (median 136.9 [47.7-545.5] vs. median 80.1 [28.8-149.9] pg/mg creatinine) compared to those of controls. Urine levels of EGF and MCP-1 were identical to controls at the postoperative 1-year follow-up exam. CONCLUSION: Urine levels of EGF and MCP-1 were preoperatively increased and postoperatively normalized. This study demonstrates that urine-excreted kidney cytokines may be potential biomarkers of obstruction in children with hydronephrosis. CI - Copyright (c) 2012 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved. FAU - Madsen, Mia Gebauer AU - Madsen MG AD - Department of Urology, Pediatric Section, Aarhus University Hospital, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark; The Water and Salt Research Center, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: miagebauermadsen@ki.au.dk. FAU - Norregaard, Rikke AU - Norregaard R FAU - Palmfeldt, Johan AU - Palmfeldt J FAU - Olsen, Lars Henning AU - Olsen LH FAU - Frokiaer, Jorgen AU - Frokiaer J FAU - Jorgensen, Troels Munch AU - Jorgensen TM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121208 PL - England TA - J Pediatr Urol JT - Journal of pediatric urology JID - 101233150 RN - 0 (Biomarkers) RN - 0 (CCL2 protein, human) RN - 0 (CCL3 protein, human) RN - 0 (CCL5 protein, human) RN - 0 (CXCL10 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CCL3) RN - 0 (Chemokine CCL5) RN - 0 (Chemokine CXCL10) RN - 62229-50-9 (Epidermal Growth Factor) SB - IM MH - Adolescent MH - Biomarkers/urine MH - Chemokine CCL2/*urine MH - Chemokine CCL3/urine MH - Chemokine CCL5/urine MH - Chemokine CXCL10/urine MH - Child MH - Child, Preschool MH - Epidermal Growth Factor/*urine MH - Female MH - Humans MH - Hydronephrosis/*complications/surgery MH - Infant MH - Infant, Newborn MH - Male MH - Preoperative Care MH - Prospective Studies MH - Ureteral Obstruction/diagnosis/*etiology/*urine OTO - NOTNLM OT - Epidermal growth factor OT - Hydronephrosis OT - Monocyte chemotactic peptide-1 OT - Ureteropelvic junction obstruction OT - Urinary biomarker EDAT- 2012/12/12 06:00 MHDA- 2014/07/18 06:00 CRDT- 2012/12/12 06:00 PHST- 2012/06/22 00:00 [received] PHST- 2012/11/13 00:00 [accepted] PHST- 2012/12/12 06:00 [entrez] PHST- 2012/12/12 06:00 [pubmed] PHST- 2014/07/18 06:00 [medline] AID - S1477-5131(12)00285-9 [pii] AID - 10.1016/j.jpurol.2012.11.011 [doi] PST - ppublish SO - J Pediatr Urol. 2013 Dec;9(6 Pt A):838-45. doi: 10.1016/j.jpurol.2012.11.011. Epub 2012 Dec 8.